Septal reduction therapy is accepted as a first therapeutic option for symptomatic drug-resistant hypertrophic obstructive cardiomyopathy (HOCM). Although, surgical septal myectomy is the gold standard method, alcohol septal ablation is a well-studied alternative approach in the patients with suitable anatomy. Endocardial septal ablation (ESA) therapy was relatively new defined modality and outcomes of the procedure were not clearly elucidated yet. We aimed to review the clinical aspects of ESA procedure and provide some historical background. (Anatol J Cardiol 2016; 16: 707-12)
Keywords: Ablation, hypertrophic obstructive cardiomyopathy, septal myectomy, alcohol septal ablation, radiofrequencyCopyright © 2024 The Anatolian Journal of Cardiology